Otto Eerbeek
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Delayed ischaemic contracture onset by empagliflozin associates with NHE1 inhibition and is dependent on insulin in isolated mouse hearts.
Journal: Cardiovascular research
Published: December 12, 2018
Cyclophilin D ablation is associated with increased end-ischemic mitochondrial hexokinase activity.
Journal: Scientific reports
Published: April 06, 2017
Reducing mitochondrial bound hexokinase II mediates transition from non-injurious into injurious ischemia/reperfusion of the intact heart.
Journal: Journal of physiology and biochemistry
Published: July 25, 2016
Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
Journal: Respiratory research
Published: October 13, 2014
Targeting hexokinase II to mitochondria to modulate energy metabolism and reduce ischaemia-reperfusion injury in heart.
Journal: British journal of pharmacology
Published: July 01, 2013
Pathophysiological consequences of TAT-HKII peptide administration are independent of impaired vascular function and ensuing ischemia.
Journal: Circulation research
Published: January 19, 2013
Hexokinase cellular trafficking in ischemia-reperfusion and ischemic preconditioning is altered in type I diabetic heart.
Journal: Molecular biology reports
Published: December 19, 2012
Reduced hexokinase II impairs muscle function 2 wk after ischemia-reperfusion through increased cell necrosis and fibrosis.
Journal: Journal of applied physiology (Bethesda, Md. : 1985)
Published: June 23, 2012
Ratiometric intracellular calcium imaging in the isolated beating rat heart using indo-1 fluorescence.
Journal: Journal of applied physiology (Bethesda, Md. : 1985)
Published: June 23, 2004
Showing 1-10 of 10
Last Updated: 09/26/2026